CUSTOM PRECISION DIE CUTTING SOLUTIONS FOR THE MEDICAL INDUSTRY

ISO 13485:2016 is an international standard for Quality Management Systems (QMS) for manufacturers in the medical industry, ensuring that die-cutting and converting services meet stringent requirements for safety and quality. For a medical die-cutter and contract manufacturer like JBC Technologies, being ISO 13485 Certified means adhering to a strict framework that governs risk management, full traceability for medical-grade materials, and process validation. In short, being an ISO 13495 Certified converter ensures the entire die-cutting process is controlled for maximum traceability, quality, and repeatability. 

IQ (installation qualification), OQ (operational qualification), and PQ (process qualification) are the three pillars that make up process validation, ensuring that the converting process is robust and repeatable:

• Installation Qualification (IQ) - This ensures that all of our physical die-cutting and converting equipment has been installed and integrated correctly.
• Operational Qualification (OQ) - This is where we test and verify our equipment's "operating window", confirming that our process operates reliably within defined limits and produces acceptable output across worst-case scenarios. 
• Performance Qualification (PQ) - This is where we guarantee that the entire process can repeatedly produce consistent high-quality parts under real-world conditions, making sure every lot meets your specifications and quality requirements. 

Change Control is managed through a formal, risk based process that evaluates the impact of any proposed change to materials, tooling, processes, suppliers, or inspection methods. Each change is reviewed for potential effects on form, fit, function, and regulatory compliance, with required customer notification, approvals, and revalidation completed before implementation. This ensures product integrity and regulatory compliance are maintained throughout the product lifecycle.

Our multiple cleanroom manufacturing environments are ISO Class 8 Certified, designed to allow a maximum of 3,520,000 particles per cubic meter of air, as outlined by ISO 14644 guidelines. 

Material risk is mitigated through dual‑sourcing strategies, approved alternate materials, supplier agreements, and proactive forecasting aligned to customer demand. Where appropriate, safety stock or bonded inventory programs are implemented, and material lifecycles are monitored to avoid obsolescence. Early engagement with customers allows mitigation strategies to be deployed before shortages impact supply continuity.

DFM support begins early in NPI through collaborative design reviews focused on material selection, geometry, tolerances, and assembly compatibility. Converting specific constraints—such as minimum feature sizes, cut spacing, liner strategy, and process capability—are reviewed to reduce risk and cost. Prototyping and pilot builds are used to validate assumptions before full scale production.

Slug removal challenges are addressed through a combination of tooling design, cut sequencing, material selection, and process controls. Techniques may include low tack liners, vacuum assist, ejection features, optimized blade spacing, or design modifications to improve manufacturability. These approaches help ensure clean part release without damaging delicate features or slowing production.

Yes, JBC is very capable of die-cutting and converting differential double-sided medical-adhesives for a wide range of medical and consumer wellness applications. Differential double-sided adhesives are commonly found in attachment layer tapes in medical device stack-ups and in consumer wellness products like fashion tapes. 

Higher‑modulus (stiffer) substrates tend to resist conformability, which can lead to edge lift, discomfort, and reduced wear‑time—especially on contoured anatomy. Lower‑modulus or elastomeric substrates better accommodate movement and curvature, improving adhesion longevity and patient comfort. Balancing stiffness, thickness, and elastic recovery is critical for extended‑wear applications.

To determine which substrate, or carrier layer, is right for your medical adhesive stack-up, it's critical to perform real-world wear tests to ensure the patch you've designed actually holds up in practice. JBC's rapid prototyping capabilities allow you to quickly test form, fit, and function for a wide range of medical-grade materials. 

Liner release force must be tightly controlled to ensure consistent, reliable part presentation during automated pick‑and‑place or peel‑and‑apply operations. Excessive release force can cause part deformation or misfeeds, while too little force can lead to premature release or handling issues. Proper liner selection and validation are essential for stable high‑speed automation.

JBC utilizes a multi-camera inline vision defect detection system to guarantee that each medical component that leaves our presses is defect-free - from small prototype runs to thousands of high-volume components. Our multi-camera system follows a good, better, best process: 

Tier 1: Presence/Absence Analysis - For lower risk components, a pattern recognition system verifies part counts and identifies the presence or absence of critical design features. 

Tier 2: Verifying Part Dimensions - Tier 2 leverages a more advanced system that goes beyond identifying crucial design features and measures part dimensions in real time to catch even the slightest deviations.

Tier 3: Any Defect, Anywhere - This is the most stringent tier, powered by an AI-driven any defect, anywhere system that can be trained to identify even the slightest imperfections in each component. 

Key DFM constraints include minimum feature sizes, blade to blade spacing, material thickness limits, achievable tolerances, liner strategy, and compatibility with high volume processes. Designs with unnecessary cut outs, extremely tight internal radii, or unsupported material behaviors increase risk and cost. Early DFM collaboration ensures the design aligns with converting capabilities while meeting functional requirements.

While the initial price tag for offshore medical device manufacturing looks better on paper, many of the "hidden" costs and challenges associated with offshore manufacturing can quickly drive this number up and slow your supply chain. 

Offshore manufacturers are subject to fluctuating tariffs, quality risks, slow overseas supply chains, trade disputes, and geopolitical uncertainty. What began as a cheap unit cost on paper can quickly become a tariff-laden, expensive, and delayed project. 

The benefits of working with a domestic converting partner are not directly reflected in the initial per-unit price, but rather in the lowered Total Cost of Ownership (TCO) and improved supply chain resiliency and responsiveness you receive in return. Medical-OEMs and startups benefit from: 

• Improved go-to-market speeds
• Supply chain resilience & responsiveness
• No fluctuating tariff costs
• Increased quality and consistency

Check out this blog for a deeper dive into the benefits of working with a U.S-based converting partner: Tariffs, Tension, and Opportunity: The Importance of U.S-based Manufacturing

Adhesive performance through sterilization depends on chemistry and construction. Many acrylic-based medical pressure-sensitive adhesives perform well through both EtO and Gamma, while some rubber-based systems may be more sensitive to radiation exposure. Adhesive selection is validated against the specific sterilization method, dose, and post-sterilization performance requirements to ensure bond integrity is maintained.